Uncategorized

Home 9 Category: Uncategorized

EvlaBio raises €21 million Seed Funding to Develop a Monoclonal Antibody for the Treatment of Left Ventricular Hypertrophy

by supportmlcom | Jul 7, 2025 | Uncategorized

Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia

by aline | Jun 4, 2025 | Uncategorized

Augustine Therapeutics announces first patient dosed in Phase I for the treatment of Charcot-Marie-Tooth disease

by supportmlcom | May 27, 2025 | Uncategorized

SparingVision Presents PRODYGY data and Research Update in Two Oral Presentations at ASGCT 2025

by supportmlcom | May 21, 2025 | Uncategorized

Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell FactoryTM for CAR-T therapy manufacturing

by supportmlcom | May 6, 2025 | Uncategorized

Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOLTM PF for the Treatment of Presbyopia

by supportmlcom | Apr 9, 2025 | Uncategorized

« Older Entries

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Uncategorized

EvlaBio raises €21 million Seed Funding to Develop a Monoclonal Antibody for the Treatment of Left Ventricular Hypertrophy

Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia

Augustine Therapeutics announces first patient dosed in Phase I for the treatment of Charcot-Marie-Tooth disease

SparingVision Presents PRODYGY data and Research Update in Two Oral Presentations at ASGCT 2025

Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell FactoryTM for CAR-T therapy manufacturing

Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOLTM PF for the Treatment of Presbyopia

Recent Posts

Recent Comments

AdBio partners is a VC firm with a strong entrepreneurial spirit, specialized in early-stage investment in the most promising life sciences startups in Europe.

Menu

Contact

Follow Us